Association analysis of a highly polymorphic CAG repeat in the human potassium channel gene KCNN3 and migraine susceptibility

BMC Medical Genetics

Volumn 6, Issue , 2005, Pages

  Curtain, Robert ^a   Sundholm, James ^a   Lea, Rod ^a,b   Ovcaric, Mick ^a   MacMillan, John ^c   Griffiths, Lyn ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; GENOMIC DNA; POLYGLUTAMINE; POTASSIUM; KCNN3 PROTEIN, HUMAN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EXON; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; KCNN3 GENE; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; TRINUCLEOTIDE REPEAT; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 26444503729     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-6-32     Document Type: Article

References (35)

1. Headache Classification Subcommittee of the International Headache Society: The international classification of headache disorders: 2nd edition. Cephalalgia 2004, 24(suppl 1):9-160.
2. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB: The inheritance of migraine with aura estimated by means of structural equation modelling. J Med Genet 1999, 36(3):225-7.
3. Launer LJ, Terwindt GM, Ferrari MD: The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999, 53:537-542.
4. Owen MJ, McGuffin P: Association and linkage: complimentary strategies for complex disorders. J Med Genet 1993, 30:638-639.
5. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
6. Nöthen MM, Propping P, Fimmers R: Association versus linkage studies in psychosis genetics. J Med Genet 1993, 30:634-637.
7. Kullmann DM, Hanna MG: Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol 2002, 1(3):157-66.
8. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR: Familial hemiplegic migraine and episodic ataxia type2 are caused by mutations in the Ca2 + channel gene CACNL1A4. Cell 1996, 87:543-52.
9. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G: Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha-2 subunit associated with familial hemiplegic migraine type 2. Nature Genet 2003, 33:192-196.
10. Fumal A, Schoenen J: [Genetics of migraines: from ionic channels to single nucleotide polymorphisms?]. Rev Med Liege 2004, 59(6):367-77.
11. Wessman M, Kaunisto MA, Kallela M, Palotie A: The molecular genetics of migraine. Ann Med 2004, 36(6):462-73.
12. Lea RA, Curtain RP, Hutchins C, Brimage PJ, Griffiths LR: Investigation of the CACNA1A gene as a candidate for typical migraine susceptibility. Am J Med Genet 2001, 105(8):707-12.
13. Jen JC, Kim GW, Dudding KA, Baloh RW: No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch Neurol 2004, 61(6):926-8.
14. Curtain RP, Lea RA, Tajouri L, Haupt L, Ovcaric M, MacMillan J, Griffiths L: Analysis of Chromosome 1 Microsatellite Markers and the FHM-2 (ATP1A2 Gene) Mutations in Migraine With and Without Aura Pedigrees. Neurological Research 2005 in press. accepted 27/02/05
15. Wittekindt O, Jauch A, Burgert E, Schärer L, Holtgreve-Grez H, Yvert G, Imbert G, Zimmer J, Hoehe M, Macher J, Chiaroni P, Calker D, Crocq M, Morris-Rosendahl D: The human small conductance calcium-regulated potassium channel gene (hSKCs3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia. Neurogenetics 1998, 1:259-265.
16. Chandy KG, Fantino E, Wittekind O, Kalman K, Tong L, Ho T-H, Gutman GA, Crocq M-A, Fargus JJ: Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate gene for schizophrenia and bipolar disorder. Mol Psychiatry 1998, 3:32-37.
17. Köhler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Adelman JP: Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996, 273:1709-1714.
18. Keryanov S, Gardner KL: Physical mapping and characterization of the human Na, K-ATPase isoform, ATP1A4. Gene 2002, 292(1-2):151-66.
19. Austin CP, Holder DJ, Ma L, Mixson LA, Caskey CT: Mapping of KCNN3 to chromosome 1q21 and investigation of linkage of CAG repeat polymorphism to schizophrenia. Mol Psychiatry 1999, 4:261-266.
20. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC: Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997, 15(1):62-9.
21. Frontali M: Spinocerebellar ataxia type 6: channelopathy or glutamine repeat disorder? Brain Res Bull 2001, 56(3-4):227-31.
22. Flink MT, Atchison WD: Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. J Bioenerg Biomembr 2003, 35(6):697-718.
23. Villalon CM, Centurion D, Valdivia LF, de Vries P, Saxena PR: Migraine: pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol 2003, 1(1):71-84.
24. Peroutka SJ: Migraine: a chronic sympathetic nervous system disorder. Headache 2004, 44(1):53-64.
25. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR: Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 2000, 3:35-40.
26. Blin N, Stafford DW: Isolation of high molecular-weight DNA. Nucleic Acids Res 1976, 3:2303.
27. Miller SA, Dykes DD, Plensky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988, 16:1215.
28. Sham P, Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59:97-105.
29. Everett CM, Wood NW: Trinucleotide repeats and neurodegenerative disease. Brain 2004, 127(Pt 11):2385-405.
30. Ophoff RA, van den Maagdenberg AM, Roon KI, Ferrari MD, Frants RR: The impact of pharmacogenetics for migraine. Eur J Pharmacol 2001, 413(1):1-10.
31. Codignola A, Tarroni P, Clementi F, Pollo A, Lovallo M, Carbone E, Sher E: Calcium channel subtypes controlling serotonin release from human cell lung carcinoma cell line. J Biol Chem 1993, 268:26240-26247.
32. Ferrari MD: Migraine. Lancet 1998, 351(9108):1043-51.
33. Goadsby PJ, Zagami AS, Lambert GA: Neural processing of cardiovascular pain: a synthesis of the central structures involved in migraine. Headache 1991, 31:365-371.
34. Glatt SJ, Faraone SV, Tsuang MT: CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies. Am J Med Genet B Neuropsychiatr Genet 2003, 121(1):14-20.
35. Mossner R, Weichselbaum A, Marziniak M, Freitag CM, Lesch KP, Sommer C, Meyer J: A highly polymorphic poly-glutamine stretch in the potassium channel KCNN3 in migraine. Headache 2005, 45(2):132-6.